This is a preview of subscription content, log in via an institution to check access.
Reference
Rendas-Baum R, et al. Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials. Rheumatology : 28 Apr 2017. Available from: URL: http://doi.org/10.1093/rheumatology/kex087
Rights and permissions
About this article
Cite this article
Tofacitinib reduces medical costs and risk of job loss in RA. PharmacoEcon Outcomes News 778, 32 (2017). https://doi.org/10.1007/s40274-017-4009-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4009-5